Phathom Pharmaceuticals

#GERDtoKnow is back! Ahead of #GERDAwarenessWeek (Nov. 22-28), we're separating #GERD myths from facts. Follow along and learn more at bit.ly/GERDRelief.

We were proud to celebrate the nomination of our #GERD treatment for “Best Pharmaceutical Product” at the 2026 #PrixGalien USA Awards! Thank you to @GalienFdn for the recognition, and congratulations to all nominees and winners!

Eligible patients with commercial insurance may now pay as little as $0* per fill for VOQUEZNA® (vonoprazan) tablets at BlinkRx, with free home delivery and prior authorization support. Eligibility requirements, benefit limits, and terms and conditions apply. Learn more: bit.ly/4imSZq5 See full terms: bit.ly/VOQUEZNA-savings

Three years ago, we received our first FDA approval for VOQUEZNA® (vonoprazan). Today, we're proud to celebrate another milestone: more than 2 MILLION prescriptions dispensed in the U.S. since launch! Thank you to the healthcare providers, patients, and our #PhathomPhamily who have made this journey possible.

#NEWS $PHAT reported solid Q3 2026 financial results and provided a business update. Learn more: bit.ly/4ySidTr

New in @TheLancetOncol: 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 was linked to ~760,000 cancer cases worldwide in 2024, numerically more than any other infection. Testing, treating and confirming eradication of 𝘏. 𝘱𝘺𝘭𝘰𝘳𝘪 infection are some of the most meaningful steps toward prevention. Learn more: bit.ly/4BkP1qH #HPylori #GIHealth

Tune in today at 11 AM ET: our CMO, Eckhard Leifke, MD, joins this year's “Best Pharmaceutical Product” category nominees at #GalienWeek to talk innovation in GI care. Join us live: bit.ly/4z7yZ22

Mark your calendar: our CMO, Eckhard Leifke, MD, joins the 2026 #GalienWeek of Innovation webinar on Wed., Oct. 28 at 11 AM ET to discuss innovation in #GI care. Register & tune in: bit.ly/4z7yZ22

Football season is in full swing, and our #PhathompHamily is bringing the spirit! Thanks to everyone who shared their game day pride! 🏈 #LifeAtPhathom

#NEWS $PHAT to report Q3 2026 financial results and provide an update on business progress on Thursday, October 29 at 8 a.m. ET. Read more: bit.ly/4zHdULH

Looking back on #ACG2026, we’d like to thank everyone who engaged with us at our booth and presentations. It was a pleasure to connect with the #GI community and share more about our mission to improve the lives of people living with GI disorders. Catch up on Phathom’s highlights from ACG: bit.ly/4yJJQ1T

Phathom has once again been named one of the 2026 BEST WORKPLACES IN BIOPHARMA! Thank you to our #PhathomPhamily for making this a special place where pHenomenal work happens. Find out what makes #LifeAtPhathom award-worthy: bit.ly/4hKehz8 #BestWorkplaces

Join us TODAY for a live product theater during #ACG2026! You'll hear more about our approved treatment option for adults with #GERD. See you there!

New data presented at #ACG2026 highlight research evaluating our #GERD treatment, including a cost-effectiveness model, real-world patient characteristics & efficacy across BMI subgroups. Read more: bit.ly/4yJJQ1T

We’re looking forward to joining the #GI community in Nashville for the #ACG2026 Annual Meeting. Be sure to stop by Booth 323 to meet members of our team and read our press release to learn more about Phathom’s data and presence during the premier GI clinical meeting: bit.ly/3TSaQ03

Join us on Monday, October 12, at 3:45 pm CDT for a live Product Theater presentation at #ACG2026 to learn more about the clinical efficacy and safety profile of VOQUEZNA® (vonoprazan).

#WereHiring! Meet the #PhathomPhamily at #ACG2026 in Nashville (Booth 323) and discover how you can make an impact in #GI care. Explore our culture and open roles here: phathompharma.com/life-at-ph…

Phathom is headed to Nashville! Join us at the ACG 2026 Annual Meeting – the Premier #GI Clinical Meeting – and stop by our Booth (323) to learn how we’re making an impact with our development and commercialization of GI treatments. #ACG2026

Phathom is headed to Chula Vista, CA for the 2026 9th Annual @GastroHepAPP National Conference from October 1-3! We’re looking forward to connecting live with advanced practice providers (APPs) from across the country and hearing their perspectives on treating and managing patients with #GI disorders. Stop by the Phathom booth in the exhibit hall to meet members of our team. Hope to see you there!

#NEWS $PHAT announces patient screening has begun in pHalcon-NERD-302, a #Phase3 #clinicaltrial evaluating an investigational as-needed dosing regimen in adults with Non-Erosive #GERD. Read more: bit.ly/NERD302